Market Overview

TransEnterix Schedules Second Quarter 2018 Financial and Operating Results Conference Call for August 7, 2018


TransEnterix, Inc. (NYSE:TRXC) announced today that it plans to
release second quarter 2018 financial and operating results before the
market opens on Tuesday, August 7, 2018. Todd M. Pope, President and
Chief Executive Officer, and Joseph P. Slattery, Executive Vice
President and Chief Financial Officer, will host a conference call to
discuss these results starting at 8:30 am Eastern Time the same day. The
call will be concurrently webcast.

To listen to the conference call on your telephone, please dial
844-804-5261 for domestic callers and 612-979-9885 for international
callers, and reference conference ID 4388237 approximately ten minutes
prior to the start time. To access the live audio webcast or archived
recording, use the following link
The replay will be available on the Company's website.

About TransEnterix

TransEnterix is a medical device company that is digitizing the
interface between the surgeon and the patient to improve minimally
invasive surgery by addressing the clinical and economic challenges
associated with current laparoscopic and robotic options in today's
value-based healthcare environment. The Company is focused on the
commercialization of the Senhance™ Surgical System, which digitizes
laparoscopic minimally invasive surgery. The system allows for robotic
precision, haptic feedback, surgeon camera control via eye sensing and
improved ergonomics while offering responsible economics. The Senhance
Surgical System is available for sale in the US, the EU and select other
countries. For more information, visit

View Comments and Join the Discussion!